Rafael Holdings, Inc. Return Tang Equity
Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
- Rafael Holdings, Inc. return tang equity for the quarter ending 2026-04-30 was -54.28%, a change of -12.82% year-over-year.
- Rafael Holdings, Inc. return tang equity for the quarter ending 2026-01-31 was -53.06%, a change of 21.45% year-over-year.
- Rafael Holdings, Inc. return tang equity for the quarter ending 2025-10-31 was -45.89%, a change of 8.97% year-over-year.
- Rafael Holdings, Inc. return tang equity for the quarter ending 2025-07-31 was -39.41%, a change of 2.88% year-over-year.
- Rafael Holdings, Inc. return tang equity for fiscal 2025 was -39.41%, a change of 2.88% from fiscal 2024.
- Rafael Holdings, Inc. return tang equity for fiscal 2024 was -42.29%, a change of -40.35% from fiscal 2023.
- Rafael Holdings, Inc. return tang equity for fiscal 2023 was -1.95%, a change of 126.72% from fiscal 2022.
- Rafael Holdings, Inc. return tang equity for fiscal 2022 was -128.67%, a change of -111.76% from fiscal 2021.
- Available history
- 2016-07-31 to 2026-04-30
- Data captured
Historical Return Tang Equity
Annual Return Tang Equity
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |